Patient P-01320
Synthetic patientNBL-101 · Day 91 · 65–74 · F · baseline S09Steering view · 3DOpen companion preview
Therapy response
Unstable
Tolerance
Favorable
GI state
Improving
Inflammatory state
Favorable
Nutritional resilience
Favorable
Discontinuation risk
2%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 NBL-101 started — Baseline state S09
- Day 10 Trajectory diverged from prediction — Observed response fell below the model's expected path.
- Day 14 HY-01 recommended — Hydration Protocol HY-01
- Day 15 Patient accepted — Started HY-01 in the companion
- Day 19 GI symptom burden −17% vs expected — Hydration Protocol HY-01
- Day 25 Tolerance state changed — Unstable → Improving
What changed?
Trajectory began diverging from predicted response on Day 10.
Primary contributors, last 14 days
- GI instability-12
- Nutritional resilience+4
- Inflammatory activity-3
- Toxicity+3
What helped?
- Hydration Protocol HY-01Day 14Result: symptom burden −17%
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
GI burden
Companion0/100
improving · -13.3 vs previous 14 d
Toxicity
Blood18.4/100
worsening · +2.0 vs previous 14 d
Sleep quality
Wearable53.9/100
improving · +4.7 vs previous 14 d
Energy level
Daily log6.4/10
improving · +0.3 vs previous 14 d
Stress level
Daily log2.9/10
improving · -0.7 vs previous 14 d
Steps
Wearable6,219
improving · +244 vs previous 14 d
Adherence
Companion94.3 %
stable · -2.8 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →Heading towards failing · 87 from the failing basin, 44 from restoration.
Would help
- No untried action with strong evidence. Compose one from primitives.
Would not help
- Keep simple carbs lowGI +6.1 next day on high-intake days · n 18
- Keep fat lowGI +5.9 next day on high-intake days · n 13
- Keep alcohol lowGI +2.7 next day on high-intake days · n 19
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Simple carbohydrates+6.1detractor · 95%
- Dietary fat load+5.9detractor · 95%
- Alcohol+2.7detractor · 57%
- Insoluble fibre-1.9no signal · 44%
- Spicy / capsaicin-1.4no signal · 23%
- Histamine load-0.7no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Butyrate / short-chain fatty acid production ↓60
- MicrobiomeButyrate capacity 42/100
- MicrobiomeF. prausnitzii depleted
- Drug metabolism and exposure ↑35
- DNADPYD *2A → slower clearance
- Mucosal barrier integrity ↓30
- MicrobiomeAkkermansia low → thinner mucus layer
- Inflammatory signalling ↓20
- MicrobiomeBacteroides fragilis expansion
DNA
Fictional pharmacogenomic panel
- DPYD *2A heterozygousSlower drug clearance
- CYP2D6 Normal metabolizerExpected exposure
- MTHFR C677TReduced folate turnover
Microbiome
Shannon diversity 2.4 · butyrate capacity 42/100
- Akkermansia muciniphilaLow
- Faecalibacterium prausnitziiLow
- Bacteroides fragilisHigh
- Bifidobacterium longumNormal
- EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 60 ms
- Sleep
- 6.9 h
- Steps
- 4,916
- Resting HR
- 55 bpm
Daily log: GI score 0, nutritional resilience 69, adherence 94.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
- Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
- Log the daily check-in; one line is enough
- Keep the current walking rhythm
- Keep the sleep window steady
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the scheduled dose as agreed with your care team
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.